Chinese VCs poured $1.4 billion into U.S. biotech firms in the three months ending March 31, accounting for 40% of the $3.7 billion that the companies raised in the period overall, PitchBook data shows. The post Chinese VC funds pumping money into US biotech as Beijing chases new cures appeared first on DealStreetAsia.